Skip to content

Clinical study in treatment of asthma by acupoint sticking therapy based on Raman spectrum in monitoring of dermatitis degree

Clinical study in treatment of asthma by acupoint sticking therapy based on Raman spectrum in monitoring of dermatitis degree

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016644
Enrollment
Unknown
Registered
2018-06-14
Start date
2018-06-21
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

Health Group:Placebo application

Sponsors

Jiangsu Province Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. In line with the diagnostic criteria of asthma in western medicine, there is a clear history of recurrent asthma, and the severity is more than moderate; 2. Conform to the above standard of TCM syndrome diagnosis; 3. Patients with perennial seizures were controlled by drug control; 4. Patients with intermittent seizures were in a non acute attack; 5. The resident population of Nanjing has a fixed contact mode, with the possibility of follow-up and good compliance. 6. Aged 18~75 years; 7. The signing of the informed consent; Healthy persons are included in the criteria: (1) Healthy persons with normal physical examination; (2) Patients without asthma and acupoint application; (3) No skin damage; (4) The signing of the informed consent.

Exclusion criteria

Exclusion criteria: 1. Combined with other severe cardiopulmonary diseases, bronchiectasis and pleural lesions; 2. Patients with severe primary diseases such as liver, kidney or hematopoietic system, mental and malignant tumors; 3. Diabetics with uncontrolled blood glucose; 4. Skin allergies to adhesive tape, research medicine and excipients; 5. The injured skin or other diseases may affect the local medication, such as skin diseases; 6. Women who are lactating, gestation or preparing for pregnancy; 7. Nearly 3 months or participating in other experimental researchers; 8. According to the judgment of the researchers, other lesions or situations that have the possibility of reducing the possibility of entering the group or complicating the group, such as frequent changes in the working environment.

Design outcomes

Primary

MeasureTime frame
ACT;AQLQ;Recurrence times;

Secondary

MeasureTime frame
Skin reaction;

Countries

China

Contacts

Public ContactLiu Lanying

Jiangsu Province Hospital of Chinese Medicine

bluelany@163.com+86 13770625942

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026